Suministro por exclusividad de fármaco Ciltabtagen Autoleucel medicamento Carvikti con destino a las Farmacias hospitalarias del Área de Salud de Badajoz
TED · 371150-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Gerencia del Área de Salud de Badajoz in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Mirum Pharmaceuticals International, B. V. | 2 | €530,568 | 2026-08-07 |
| BIOGEN SPAIN S.L. | 1 | €542,880 | 2026-08-13 |
| GILEAD SCIENCES S.L. | 1 | €509,898 | 2026-09-14 |
| Waters Cromatografía, S.A. | 1 | €251,053 | 2026-09-14 |
| GILEAD SCIENCES, S.L. | 1 | €242,404 | 2026-06-12 |
Full buyer profile: what Gerencia del Área de Salud de Badajoz buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
El fármaco CILTACABTAGEN AUTOLEUCEL, medicamento CARVYKTI® es necesaria para que el que el paciente mejore su morbilidad y la calidad de vida existente.
Similar tenders
Closest by meaning — across languages, via embeddings.